Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways

Journal of Neuroscience

Volumn 22, Issue 8, 2002, Pages 3025-3032

  Yang, Libang ^a,c   Lindholm, Kristina ^a   Konishi, Yoshihiro ^a,d   Li, Rena ^a   Shen, Yong ^a,b  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Neurodegeneration; Neuronal survival; NF B; p38 MAP kinase; TNF receptor; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BRAIN; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; HIPPOCAMPUS; IMMUNE SYSTEM; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0037092420     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-08-03025.2002     Document Type: Article

References (50)

1. Akama KT, Van Eldik LJ (2000) β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNF-α)-dependent, and involves a TNF-α receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275:7918-7924.
2. Akassoglou K, Probert L, Kontogergos G, Kolias G (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158:438-445.
3. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice. Am J Pathol 153:801-813.
4. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP-Y (2001) TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
5. Baggiolini M (2001) Chemokines in pathology and medicine. J Intern Med 250:91-94.
6. 2+ accumulation. Proc Natl Acad Sci USA 92:9328-9332.
7. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834.
8. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377.
9. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788-794.
10. Carr DB, Goate A, Phil D, Morris JC (1997) Current concepts in the pathogenesis of Alzheimer's disease. Am J Med 103:3S-10S.
11. Cavaillon JM (2001) Pro- versus anti-inflammatory cytokines: Myth or reality. Cell Mol Biol 47:695-702.
12. Chao MV (1994) The p75 neurotrophin receptor. J Neurobiol 25:1373-1385.
13. Cheng B, Christakos S, Mattson MP (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139-153.
14. Collins JS, Perry RT, Watson Jr B, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Cambell RD, Go RC (2000) Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer's disease: The NIMH Alzheimer's disease genetics initiative. Am J Med Genet 96:823-830.
15. Dowling P, Shankg G, Raval S, Menonna J, Cook S, Husar W (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
16. D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15:7293-7300.
17. D'Souza SD, Alinauskas KA, Antel JP (1996) Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43:289-298.
18. Eikelenboom P, Zhan SS, van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450.
19. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillet N, Sheehan KF, Schreiber RD, Goeddel DV, Moore MW (1994) Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
20. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G (1991) Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 129:318-320.
21. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18:1283-1287.
22. Guo YL, Kang B, Han J, Williamson JR (2001) p38beta MAP kinase protects rat mesangial cells from TNF-alpha-induced apoptosis. J Cell Biochem 82:556-565.
23. Heller A, Song K, Fan N, Chang DJ (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56.
24. Hisahara S, Shoji S, Okano H, Miura M (1997) ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 172:1193-1200.
25. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
26. Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1:495-504.
27. Jacob CO, McDevitt HO (1988) Tumor nucrosis factor-α in murine autoimmune "lupus" nephritis. Nature 331:356-358.
28. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 87:968-972.
29. Kamegai M, Niijima K, Kunishita T, Nishizawa M, Ogawa M, Araki M, Ueki A, Konishi Y, Tabira T (1990) Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron 4:429-436.
30. Kim G-M, Xu J, Xu J, Song S-K, Yan P, Ku G, Xu XM, Hsu CY (2001) Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J Neurosci 21:6617-6625.
31. Kruger R, Hardt C, Tschentscher F, Jackel S, Kuhn W, Muller T, Werner J, Wortalla D, Berg D, Kuhnl N, Fuchs GA, Santos EJ, Przuntek H, Epplen JT, Schols L, Riess O (2000) Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm 107:553-562.
32. Leist M, Gantner F, Jilg S, Wendel A (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316.
33. Liu Z, Hsu H, Goeddel DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JND activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
34. Liu J, Marino W, Wong G, Grail D, Dunn A, Bettadapura J, Savin AJ, Old L, Bernard CCA (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83.
35. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359.
36. Lue L-F, Rydel R, Brigham EF, Yang L-B, Hampel H, Murphy Jr GM, Brachova L, Yan S-D, Walker DG, Shen Y, Rogers J (2001) Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35:72-79.
37. Malgaroli A, Tsien RW (1992) Glutamate-induced long-term potentiation of the frequency of miniature synaptic currents in cultured hippocampal neurons. Nature 357:134-139.
38. Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Cytokines in Parkinson's disease. J Neural Transm Suppl 58:143-151.
39. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483-490.
40. Pleasure S, Page C, Lee V (1992) Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12:1802-1815.
41. Rothwell NJ, Luheshi GN (1996) Brain TNF: Damage limitation or damaged reputation? Nat Med 2:746-747.
42. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370.
43. Shen Y, Li R, Shiosaki K (1997) Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and β-amyloid toxicity in human neuronal cell line. J Biol Chem 272:77-81.
44. Shrikant P, Benveniste EN (1996) The central nervous system as an immunocompetent organ: Role of glial cells in antigen presentation. J Immunol 157:1819-1822.
45. Sipe KJ, Srisawasdi D, Dantzer R, Kelley KW, Weyhenmeyer JA (1996) An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line. Mol Brain Res 38:222-232.
46. Tartaglia LA, Merrill A, Wong GW, Goedell DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-854.
47. Viviani B, Corsini E, Galli CL, Marinovich M (1998) Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 150:271-276.
48. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenbeele P, Fiers W (1997) Cell death induction by receptors of the TNF family: Towards a molecular understanding. FEBS Lett 410:96-106.
49. Yates SL, Burgess LH, Kocsis-Angle J, Antal JM, Dority MD, Embury PB, Piotrkowski AM, Brunden KR (2000) Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem 74:1017-1025.
50. Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP (1999) Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci 19:8856-8865.